Wu, X., Zhang, Y., Li, Z., Alvarez, A., Lauand, F., Melas‐Melt, L., . . . Mu, Y. (2025). Early Glycemic Control With iGlarLixi Versus IDegAsp in Chinese Adults With Type 2 Diabetes: A Post Hoc Analysis of the Soli‐D Study. Wiley. https://doi.org/10.1111/1753-0407.70171
Chicago Style (17th ed.) CitationWu, Xiaohong, et al. Early Glycemic Control With IGlarLixi Versus IDegAsp in Chinese Adults With Type 2 Diabetes: A Post Hoc Analysis of the Soli‐D Study. Wiley, 2025. https://doi.org/10.1111/1753-0407.70171.
MLA (9th ed.) CitationWu, Xiaohong, et al. Early Glycemic Control With IGlarLixi Versus IDegAsp in Chinese Adults With Type 2 Diabetes: A Post Hoc Analysis of the Soli‐D Study. Wiley, 2025. https://doi.org/10.1111/1753-0407.70171.
Warning: These citations may not always be 100% accurate.